ISABEL
CASTREJÓN FERNÁNDEZ
Profesora asociada
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (9)
2023
-
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81
2022
-
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis
Reumatologia Clinica, Vol. 18, Núm. 8, pp. 443-452
-
SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment
Reumatologia Clinica, Vol. 18, Núm. 9, pp. 501-512
2021
2020
-
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1170-1173
2016
2015
-
Erratum to Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis (Rheumatol Int, (2015), 10.1007/s00296-014-3189-6)
Rheumatology International
-
Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis
Rheumatology International, Vol. 35, Núm. 7, pp. 1127-1137
2010
-
Estimated cutoff points for the 28-joint disease activity score based on C-reactive protein in a longitudinal register of early arthritis
Journal of Rheumatology, Vol. 37, Núm. 7, pp. 1439-1443